Effect of coronary percutaneous revascularization on interferon-γ and interleukin-10 producing CD4+ T cells during acute myocardial infarction

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 4, 2007, Pages 791-799

  Sardella, G ^a   De Luca, L ^b   Francavilla, V ^a   Accapezzato, D ^a   Di Roma, A ^a   Gianoglio, O ^a   Colantonio, R ^a   Mancone, M ^a   Fedele, F ^a   Paroli, Marino ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b EUROPEAN HOSPITAL   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

CD4+ T cells; Coronary angioplasty; Interferon ; Interleukin 10; Myocardial infarction

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MONOCLONAL ANTIBODY; PACLITAXEL;

ACUTE HEART INFARCTION; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; IN VITRO STUDY; LYMPHOCYTOPOIESIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; ST SEGMENT ELEVATION;

EID: 37749003747     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000415     Document Type: Article

References (31)

1. Hansson G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352:1685.
2. Saidella G., D. Accapezzato, A. Di Roma, C. Iacoboni, V. Francavilla, G. Benedetti, C. Musto, F. Fedele, G. Bruno and M. Paroli. 2004. Integrin beta2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 17:165.
3. van der Wal A.C., A.E. Becker, C.M. van der Loos and P.K. Das. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36.
4. Hansson G.K. 2001. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:1876.
5. Liuzzo G., J.J. Goronzy, H. Yang, S.L. Kopecky, D.R. Holmes, R.L. Frye and C.M. Weyand. 2000. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101:2883.
6. Benagiano M., A. Azzurri, A. Ciervo, A. Amedei, C. Tamburini, M. Ferrari, J.L. Telford, C.T. Baldari, S. Romagnani, A. Cassone, M.M. D'Elios and G. Del Prete. 2003. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 100:6658.
7. Daugherty A., E. Pure, D. Delfel-Butteiger, S. Chen, J. Leferovich, S.E. Roselaar and D.J. Rader. 1997. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J. Clin. Invest. 100:1575.
8. Caligiuri G., A. Nicoletti, B. Poirier and G.K. Hansson. 2002. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109:745.
9. Ait-Oufella H., B.L. Salomon, S. Potteaux, A.K. Robertson, P. Gourdy, J. Zoll, R. Merval, B. Esposito, J.L. Cohen, S. Fisson, R.A. Flavell, G.K. Hansson, D. Klatzmann, A. Tedgui and Z. Mallat. 2006. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12:178.
10. Mor A., G. Luboshits, D. Planer, G. Keren and J. George. 2006. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur. Heart J. 27:2530.
11. Sardella G., L. De Luca, V. Francavilla, D. Accapezzato, M. Mancone, M.I. Sirinian, F. Fedele and M. Paroli. 2007. Frequency of naturally-occurring regulatory T cells is reduced in patients with ST-segment elevation myocardial infarction. Thromb. Res.
12. Roncarolo M.G., M. Battaglia and S. Gregori. 2003. The role of interleukin 10 in the control of autoimmunity. J. Autoimmun. 20:269.
13. Groux H., M. Bigler, J.E. de Vries and M.G. Roncarolo. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184:19.
14. Pinderski Oslund L.J., C.C. Hedrick, T. Olvera, A. Hagenbaugh, M. Territo, J.A. Berliner and A.I. Fyfe. 1999. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19:2847.
15. Mallat Z., S. Besnard, M. Duriez, V. Deleuze, F. Emmanuel, M.F. Bureau, F. Soubrier, B. Esposito, H. Duez, C. Fievet, B. Staels, N. Duverger, D. Scherman and A. Tedgui. 1999. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85:17.
16. Smith D.A., S.D. Irving, J. Sheldon, D. Cole and J.C. Kaski. 2001. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104:746.
17. Heeschen C., S. Dimmeler, C.W. Hamm, S. Fichtischerer, E. Boersma, M.L. Simoons and A.M. Zeiher. 2003. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107:2109.
18. Antman E.M., D.T. Anbe, P.W. Armstrong et al. 2004. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110:588.
19. Nishihira K., T. Imamura, A. Yamashita, K. Hatakeyama, Y. Shibata, Y. Nagatomo, H. Date, T. Kita, T. Eto and Y. Asada. 2006. Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur. Heart J. 27:1685.
20. Szodoray P., O. Timar, K. Veres, H. Der, E. Szomjak, G. Lakos, M. Aleksza, B. Nakken, G. Szegedi and P. Soltesz. 2006. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines - immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand. J. Immunol. 64:336.
21. Kilic T., D. Ural, E. Ural, Z. Yumuk, A. Agacdiken, T. Sahin, G. Kahraman, G. Kozdag, A. Vural and B. Komsuoglu. 2006. Relation between pro-inflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 92:1041.
22. Caligiuri G., G. Paulsson, A. Nicoletti, A. Maseri and G.K. Hansson. 2000. Evidence for antigen-driven T-cell response in unstable angina. Circulation 102:1114.
23. Methe H., S. Brunner, D. Wiegand, M. Nabauer, J. Koglin and E.R. Edelman. 2005. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J. Am. Coll. Cardiol. 45:1939.
24. Baran J., D. Kowalczyk, M. Ozog and M. Zembala. 2001. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin. Diagn. Lab. Immunol. 8:303.
25. Gibson C.M., D. Karmpaliotis, I. Kosmidou, S.A. Murphy, A.J. Kirtane, D. Budiu, K.K. Ray, H.C. Herrmann, N. Lakkis, R. Kovach, W. French, J. Blankenship, H.H. Lui, T. Palabrica, L.K. Jennings, D.J. Cohen and D.A. Morrow. 2006. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. Am. J. Cardiol. 97:1473.
26. Keeley E.C., J.A. Boura and C.L. Grines. 2003. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13.
27. Laarman G.J., M.J. Suttorp, M.T. Dirksen, L. van Heerebeek, F. Kiemeneij, T. Slagboom, L.R. van der Wieken, J.G. Tijssen, B.J. Rensing and M. Patterson. 2006. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N. Engl. J. Med. 355:1105.
28. Pusztai L., T.R. Mendoza, J.M. Reuben et al. 2004. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 25:94.
29. Levings M.K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt and M.G. Roncarolo. 2001. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:5530.
30. Alfonso F., R. Moreno and J. Vergas. 2005. Fatal infection after rapamycin eluting coronary stent implantation. Heart 91:51.
31. Eefting D., A. Schepers, M.R. De Vries, N.M.M. Pires, J.M. Grimbergen, T. Lagerweij, L.M. Nagelkerken, P.S. Monraats, J.W. Jukema, J.H. van Bockel and P.H.A. Quax. 2006. The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholoesterolemic APOE*3-Leiden mice. Atherosclerosis 193:335.